Addressing Skyrocketing Cancer Drug Prices Comes With Tradeoffs

Authors:

Abstract
This Viewpoint asserts that the current model for cancer drug pricing in the United States is not sustainable, harms patients and families and the health care s

This publication has 1 reference indexed in Scilit: